Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AIM Vaccine Co., Ltd. Class H (HK:6660)
:6660
6660 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$3.95 - HK$15.48
Previous CloseN/A
Volume905.00K
Average Volume (3M)2.24M
Market Cap
N/A
Enterprise ValueHK$10.12B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.65
Next Earnings
Mar 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding492,173,700
10 Day Avg. Volume3,316,360
30 Day Avg. Volume2,235,440
Standard Deviation0.32
R-Squared0.05
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
AIM Vaccine Co., Ltd. Class H News
PremiumCompany Announcements
AIM Vaccine Advances mRNA RSV Vaccine with US Clinical Trial Application
PremiumCompany Announcements
AIM Vaccine Advances with New Tetanus Vaccine Approval
PremiumCompany Announcements
AIM Vaccine Advances with New Influenza Vaccine Trial
PremiumCompany Announcements
AIM Vaccine Co., Ltd. Showcases Innovation at 2024 Event
PremiumCompany Announcements
AIM Vaccine’s Serum-Free Rabies Vaccine Nears Global Market Entry
PremiumCompany Announcements
AIM Vaccine Advances in Rabies Vaccine Innovation
PremiumCompany Announcements
AIM Vaccine Boosts Market Potential with New License
PremiumCompany Announcements
AIM Vaccine Advances with mRNA RSV Vaccine Approval---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.03% Mutual Funds
― Other Institutional Investors
99.57% Public Companies and
Individual Investors
6660 FAQ
What was AIM Vaccine Co., Ltd. Class H’s price range in the past 12 months?
AIM Vaccine Co., Ltd. Class H lowest stock price was HK$3.95 and its highest was HK$15.48 in the past 12 months.
What is AIM Vaccine Co., Ltd. Class H’s market cap?
Currently, no data Available
When is AIM Vaccine Co., Ltd. Class H’s upcoming earnings report date?
AIM Vaccine Co., Ltd. Class H’s upcoming earnings report date is Mar 27, 2025 which is in 49 days.
How were AIM Vaccine Co., Ltd. Class H’s earnings last quarter?
AIM Vaccine Co., Ltd. Class H released its earnings results on Aug 29, 2024. The company reported -HK$0.12 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.12.
Is AIM Vaccine Co., Ltd. Class H overvalued?
According to Wall Street analysts AIM Vaccine Co., Ltd. Class H’s price is currently Overvalued.
Does AIM Vaccine Co., Ltd. Class H pay dividends?
AIM Vaccine Co., Ltd. Class H does not currently pay dividends.
What is AIM Vaccine Co., Ltd. Class H’s EPS estimate?
AIM Vaccine Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AIM Vaccine Co., Ltd. Class H have?
AIM Vaccine Co., Ltd. Class H has 492,173,700 shares outstanding.
What happened to AIM Vaccine Co., Ltd. Class H’s price movement after its last earnings report?
AIM Vaccine Co., Ltd. Class H reported an EPS of -HK$0.12 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.635%.
Which hedge fund is a major shareholder of AIM Vaccine Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6660
---
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
Livzon Pharmaceutical Group
―
Sinopharm Group Co
―
Wuxi Biologics (Cayman)
―
---